SCHMC

Hesperidin Induces Apoptosis by Inhibiting Sp1 and Its Regulatory Protein in MSTO-211H Cells

Metadata Downloads
Abstract
Hesperidin, a flavanone present in citrus fruits, has been studied as potential therapeutic agents that have anti-tumor activity and apoptotic effects in several cancers, but there is no report about the apoptotic effect of hesperidin in human malignant pleural mesothelioma through the specificity protein 1 (Sp1) protein. We investigated whether hesperidin inhibited cell growth and regulated Sp1 target proteins by suppressing the levels of Sp1 protein in MSTO-211H cells. The IC50 value of hesperidin was determined to be 152.3 μM in MSTO-211H cells for 48 h. Our results suggested that hesperidin (0-160 μM) decreased cell viability, and induced apoptotic cell death. Hesperidin increased Sub-G1 population in MSTO-211H cells. Hesperidin significantly suppressed mRNA/protein level of Sp1 and modulated the expression level of the Sp1 regulatory protein such as p27, p21, cyclin D1, Mcl-1, and survivin in mesothelioma cells. Also, hesperidin induced apoptotic signaling including: cleavages of Bid, caspase-3, and PARP, upregulation of Bax, and down-regulation of Bcl-xl in mesothelioma cells. These results show that hesperidin suppressed mesothelioma cell growth through inhibition of Sp1. In this study, we demonstrated that Sp1 acts as a novel molecular target of hesperidin in human malignant pleural mesothelioma.
All Author(s)
K. A. Lee ; S. H. Lee ; Y. J. Lee ; S. M. Baeg ; J. H. Shim
Issued Date
2012
Type
Article
Keyword
RotavirusHepatitis A virusRecombinant chimera protein
Publisher
The Korean Society of Applied Pharmacology
ISSN
1976-9148
Citation Title
Biomolecules & Therapeutics
Citation Volume
20
Citation Number
3
Citation Start Page
273
Citation End Page
279
Language(ISO)
eng
DOI
10.4062/biomolther.2012.20.3.273
URI
http://schca-ir.schmc.ac.kr/handle/2022.oak/1556
Appears in Collections:
직업환경의학과 > 1. Journal Papers
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.